Pharmacokinetics of para-Aminosalicylic Acid in HIV-Uninfected and HIV-Coinfected Tuberculosis Patients Receiving Antiretroviral Therapy, Managed for Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis

The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Mycobacterium tuberculosis prompted the reintroduction of para-aminosalicylic acid (PAS) to protect companion anti-tuberculosis drugs from additional acquired resistance. In sub-Saharan Africa, MDR/XDR tuberculosis with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: de Kock, Lizanne, Sy, Sherwin K. B., Rosenkranz, Bernd, Diacon, Andreas H., Prescott, Kim, Hernandez, Kenneth R., Yu, Mingming, Derendorf, Hartmut, Donald, Peter R.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2014
Assuntos:
Clinical Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4187930/
https://ncbi.nlm.nih.gov/pubmed/25114132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03073-14
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados